2015's Biggest Medtech Companies2015's Biggest Medtech Companies

October 8, 2014

11 Slides
2015's Biggest Medtech Companies

Already have an account?

2. Medtronic plcAssuming the merger goes through as planned, Medtronic and Covidien would have roughly $27.2 billion a year in sales between them.Medtronic$17 billion in revenue in the fiscal year ended April 25, 2014Covidien$10.2 billion in revenue in the fiscal year ended Sept. 27, 2013By acquiring Covidien for $43 billion, Medtronic could give J&J a run for its money as the company with the largest device and diagnostics business. In 2013, J&J had nearly $28.1 billion in sales—roughly $10 billion more than its nearest competitor, Siemens. But Medtronic plc would be $27 billion-a-year company in itself. On top of that, both Medtronic and Covidien already had an aggressive plan to expand their presence in emerging markets. In 2015, it’s anybody’s guess which medical device company will bring in the most revenue.>>NextBackground on image: The Micra pacemaker, billed by Medtronic as the world’s smallest, is an order of magnitude smaller than current generation pacemakers. Medtronic developed the device in house, as we detailed in the article “How Medtronic Made the World's Smallest Pacemaker.”

2015's Biggest Medtech Companies

The list of the world’s 10 largest medical device companies is going to look pretty different in 2015 versus 2014.

The medical device industry is seeing some major shifts amid multibillion-dollars mergers and the decision of some diversified companies such as Philips to split up.

Here, we determine how the top medtech companies will likely rank in 2015 based on medical device revenue numbers from their most recent annual reports. For big device companies with megamerger plans, we tallied up their combined revenue and assumed that the proposed mergers, most notably Medtronic and Covidien, would pass regulatory hurdles.

Read on to find out more.

Also, we'd love to hear your thoughts regarding the uptick in medtech megamergers in 2014 in the poll below:

Brian Buntz is the editor-in-chief of MPMN and Qmed. Follow him on Twitter at @brian_buntz. Chris Newmarker is senior editor of MPMN and Qmed. Follow him on Twitter at @newmarker

Like what you’re reading? Subscribe to our daily e-newsletter.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like